Výsledky vyhledávání - "K Sunil, Naik"

Akademický článek

Effect of colchicine and aspirin given together in patients with moderate COVID-19

Autor: K. Sunil Naik, Niranjan Andhalkar, Sohal Pendse

Publikováno v: Contemporary Clinical Trials Communications, Vol 32, Iss , Pp 101070- (2023)

Background: The objective of the study was to evaluate the effect of Colchicine 0.5 mg and Aspirin 75 mg oral tablets given together on management of moderate COVID-19. Methods: The study was carried out in 122 moderate COVID-19 patients between ages

Externí odkaz: https://doaj.org/article/1039eb431bb044419c328511e7598157

Zobrazit plný text záznamu

Akademický článek

Efficacy of green jackfruit flour as a medical nutrition therapy replacing rice or wheat in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study

Autor: A. Gopal Rao, K. Sunil Naik, A. G. Unnikrishnan, James Joseph

Publikováno v: Nutrition & Diabetes, Vol 11, Iss 1, Pp 1-6 (2021)

Abstract Background/Objectives Medical nutrition therapy along with pharmacological interventions as a multidisciplinary approach is required to treat type 2 diabetes mellitus (T2DM). This study evaluated the efficacy of Jackfruit365™ green jackfru

Externí odkaz: https://doaj.org/article/ee0f89ffe8d345e8b16096d18c9ee061

Zobrazit plný text záznamu

Post-acute sequelae SARS-CoV-2 (PASC) infection and molecular signaling - A quasi-experimental study evaluating a natural supplement

Autor: Alben Sigamani, K Sunil Naik, Sangeetha Sampath Kumar

Background and Aim: Long COVID becomes an economic and public health challenge that affects the daily activities and quality of life of millions of COVID-19 survivors. Long COVID symptoms, particularly persistent fatigue, appear to be associated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cbc4f157ac481109a69e029cafe992f0
https://doi.org/10.21203/rs.3.rs-2676572/v1

Zobrazit plný text záznamu

Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial

Autor: Ameet, Dravid, Anant S, Pilawan, Anuradha, S, Dnyanesh N, Morkar, John T, Ramapuram, Kulkarni Milind, Madhukarrao, K Sunil, Naik, Milind, Bhrusundi, Raveendra, K R, Siddabathuni, Nageswaramma, Vinay, Kulkarni

Publikováno v: Medicine. 101:e31982

To evaluate the non-inferiority of low dose efavirenz (400 mg) to standard dose efavirenz (600 mg), when taken in combination with tenofovir and lamivudine in Indian patients with HIV-1 infection.An open-label, interventional phase IV study with blin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fc4341b76bc1ac4419f7d84e661884
https://doi.org/10.1097/md.0000000000031982

Zobrazit plný text záznamu

Assessment of safety and efficacy of a dietary supplement KaraLiv™ in supporting liver health: a double-blind, parallel, placebo-controlled randomized clinical trial

Autor: K. Sunil Naik, Ravikumar Rajendran, Kudiganti Venkateshwarlu, Krishna Rajendran, Rajendran Ramaswamy

Publikováno v: International Journal of Basic & Clinical Pharmacology. 10:1170

Background: The liver is responsible for many critical functions within the body. If the liver becomes diseased or injured, loss of those critical functions can cause significant damage to the body. KaraLivTM is a novel herbal formulation which conta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::95ee3890f9b0a53be9cdfbe868a8d5f0
https://doi.org/10.18203/2319-2003.ijbcp20213747

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání